218.
Leptin levels in human and rodent: measurement of plasma leptin and ob RNA
in obese and weight- reduced subjects / M. Maffei [et al.] // Nat. Med. – 1995. –
Vol. 1. – P. 1155-1161.
219.
Leptin receptor missense mutation in the fatty Zucker rat / M. S. Phillips [et
al.] // Nat. Genet. – 1996. – Vol. 13. – P. 18-19.
220.
Leptin resistance contributes to obesity and hypertension in mouse models of
Bardet-Biedl syndrome / K. Rahmouni [et al.] // J. Clin. Invest. – 2008. – Vol.
118, № 4. – P. 1458-1467.
221.
Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease /
S. B. Patel [et al.] // Curr. Hypertens. Rep. – 2008. – Vol. 10, № 2. – P. 131-137.
222.
Lindholm L. H. Should b-blockers remain first choice in the treatment of
primary hypertension? A meta-analysis / L. H. Lindholm, B. Carlberg O.
Samuelsson // Lancet. – 2005. – Vol. 366. – P. 1545- 1553.
223.
Long-term maintenance of weight loss after a very-low-calorie diet: a
randomized blinded trial of the efficacy and tolerability of Sibutramine / M.
Apfelbaum [et al.] // Am. J. Med. – 1999. – Vol. 106, № 2. 179-184.
224.
Major cardiovascular events in hypertensive patients randomized to doxazosin
vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent
heart attack trial (ALLHAT) / ALLHAT Collaborative Research Group // JAMA.
– 2000. – Vol. 283, № 15. – P. 1967-1975.
225.
Manna D. L. Basci a mechanisms in congestive heart failure. Recognizing the
role proinflammatory cytokines / D. L. Manna, J. B. Young // Chest. – 1994. –
Vol. 105. – P. 897-904.
226.
Mannucci P. M. Von Willebrand factor. A marcer of endothelial damage? / P.
M. Mannucci // Arteroscler. Thromb. Vasc. Biol. – 1998. – Vol. 18. – P. 1359-
1362.
227.
Martin K. R. The effect of carotenoids on the expression of cell surface
adhesion molecules and binding of monocytes to human aortic endothelial cell /
